Conversely, in SU-R RCC cells, CYP1B1 depletion led to reduced levels of N-cadherin and vimentin and increased ZO-1 expression following sunitinib treatment (Fig. 3E and S3F). This evidence concerns the gene VIM and renal cell carcinoma.